STOCK TITAN

Medtronic grants Michael Marinaro 42,994 options

Medtronic plc President Michael Marinaro acquired 6,547 restricted stock units on November 2, 2026; his directly held ordinary shares following the award totaled 113,353.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Medtronic plc President Michael Marinaro acquired 6,547 restricted stock units on November 2, 2026; his directly held ordinary shares following the award totaled 113,353. The units vest 100% on August 3, 2029.

He also received 16,367 performance share units at target. Depending on performance metrics over a three-year period, 39,281 shares will be issued if maximum metrics are achieved, while the units may vest at 0 shares if minimum metrics are not met. Certain performance conditions will have been satisfied on April 27, 2029. The 42,994 stock options have a $99.29 exercise price; 25% of the shares granted become exercisable per year beginning August 3, 2027, and the options expire November 2, 2036.

Insider Marinaro Michael
Role President
Type Security Shares Price Value
Grant/Award Performance Share Units F3, F4, F5 16,367 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) F6 42,994 $0.00 $0.00
Grant/Award Ordinary Shares F1, F2 6,547 $0.00 $0.00
Holdings After Transaction: Performance Share Units — 16,367 contracts (Direct); Stock Option (Right to Buy) — 42,994 contracts (Direct); Ordinary Shares — 113,353 shares (Direct)
Footnotes (6)
  1. F1. Represents restricted stock units that vest 100% on August 3, 2029.
  2. F2. Includes 890 shares acquired through dividend reinvestment since the last report filed by the reporting person.
  3. F3. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
  4. F4. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
  5. F5. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 16,367 shares will be issued. If maximum performance metrics are achieved, 39,281 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
  6. F6. These options become exercisable at the rate of 25% of the shares granted per year beginning on August 3, 2027.
Restricted stock units awarded 6,547 units Awarded November 2, 2026; vest 100% on August 3, 2029
Ordinary shares held after award 113,353 shares Directly held following the November 2, 2026 transaction
Performance share units at target 16,367 units Target performance outcome
Maximum performance-based shares 39,281 shares If maximum performance metrics are achieved
Minimum-performance vesting 0 shares PSUs may vest at this level if minimum performance metrics are not met
Stock options awarded 42,994 options Awarded November 2, 2026
Option exercise price $99.29 per share Stock option grant
restricted stock units financial
"Represents restricted stock units that vest 100% on August 3, 2029."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
performance share units financial
"Each performance share unit represents a contingent right to receive one share"
Performance share units are a type of company stock award given to employees that depend on the company meeting specific goals or targets. If these goals are achieved, the employee receives shares or the value of shares; if not, they may receive little or no compensation. This aligns employees’ interests with the company's success and encourages performance that benefits investors.
performance metrics financial
"depending on the level of certain performance metrics achieved over a three (3) year performance period"
Performance metrics are concrete numbers or ratios that show how well a business, product, or investment is doing—like speed, fuel use and mileage on a car’s dashboard. They measure things investors care about, such as sales growth, profitability, cash flow, customer retention or efficiency, so readers can compare progress, spot strengths or problems, and make informed decisions about buying, holding or selling shares.
dividend reinvestment financial
"shares acquired through dividend reinvestment since the last report"
Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many restricted stock units did MDT President Michael Marinaro receive?

On November 2, 2026, Michael Marinaro received 6,547 restricted stock units. His directly held ordinary-share position following the award was 113,353 shares; the units vest 100% on August 3, 2029.

What are the terms of Michael Marinaro's MDT stock options?

The grant covered 42,994 options with an exercise price of $99.29 per share. They become exercisable at a rate of 25% of the shares granted per year beginning August 3, 2027, and expire November 2, 2036.

What is the performance share range in Michael Marinaro's MDT award?

The award was for 16,367 performance share units at target. If maximum performance metrics are achieved, 39,281 shares will be issued; if minimum metrics are not met, the units may vest at 0 shares. The outcome depends on performance metrics over a three-year period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Marinaro Michael

(Last)(First)(Middle)
710 MEDTRONIC PARKWAY

(Street)
MINNEAPOLIS MINNESOTA 55432

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares11/02/2026A6,547(1)A$0113,353(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Share Units(3)11/02/2026A16,367 (4) (4)Ordinary Shares16,367(5)$016,367D
Stock Option (Right to Buy)$99.2911/02/2026A42,994 (6)11/02/2036Ordinary Shares42,994$042,994D
Explanation of Responses:
1. Represents restricted stock units that vest 100% on August 3, 2029.
2. Includes 890 shares acquired through dividend reinvestment since the last report filed by the reporting person.
3. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
4. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
5. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 16,367 shares will be issued. If maximum performance metrics are achieved, 39,281 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
6. These options become exercisable at the rate of 25% of the shares granted per year beginning on August 3, 2027.
Remarks:
/s/ Patricia Walesiewicz, attorney-in-fact11/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading